Cargando…

Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families

BACKGROUND: BRCA1 and BRCA2 mutations explain approximately one-fifth of the inherited susceptibility in high-risk Finnish hereditary breast and ovarian cancer (HBOC) families. EMSY is located in the breast cancer-associated chromosomal region 11q13. The EMSY gene encodes a BRCA2-interacting protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Määttä, Kirsi M., Nurminen, Riikka, Kankuri-Tammilehto, Minna, Kallioniemi, Anne, Laasanen, Satu-Leena, Schleutker, Johanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525221/ https://www.ncbi.nlm.nih.gov/pubmed/28738860 http://dx.doi.org/10.1186/s12885-017-3488-x

Ejemplares similares

Copy Number Variation Analysis in Familial BRCA1/2-Negative Finnish Breast and Ovarian Cancer
por: Kuusisto, Kirsi M., et al.
Publicado: (2013)

Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland
por: Pallonen, Terhi Aino-Sofia, et al.
Publicado: (2022)

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2018)

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
por: Kuusisto, Kirsi M, et al.
Publicado: (2011)

The EMSY threonine 207 phospho-site is required for EMSY-driven suppression of DNA damage repair
por: Jelinic, Petar, et al.
Publicado: (2017)

EMSY links breast cancer gene 2 to the 'Royal Family'
por: Yao, Jun, et al.
Publicado: (2004)

ATM c.7570G>C is a high‐risk allele for breast cancer
por: Kankuri‐Tammilehto, Minna, et al.
Publicado: (2022)

Severe Untreated Scoliosis and Early Onset Breast Cancer in a Patient with Neurofibromatosis Associated with a Nonsense Variant of NF1 Gene
por: Reinhold, Vivian, et al.
Publicado: (2023)

Neurocognitive follow‐up in adult siblings with Phelan–McDermid syndrome due to a novel SHANK3 splicing site mutation
por: Kankuri‐Tammilehto, Minna, et al.
Publicado: (2021)

Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients
por: Pelttari, Liisa M, et al.
Publicado: (2012)

Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs
por: Benusiglio, Patrick R, et al.
Publicado: (2005)

Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer
por: Wappenschmidt, Barbara, et al.
Publicado: (2020)

The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31
por: Viré, Emmanuelle, et al.
Publicado: (2014)

A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer
por: Mulrane, Laoighse, et al.
Publicado: (2014)

The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31
por: Viré, Emmanuelle, et al.
Publicado: (2014)

Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer
por: Moradian, Mike M., et al.
Publicado: (2021)

Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility
por: Quezada Urban, Rosalía, et al.
Publicado: (2018)

Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective
por: Molina-Zayas, María, et al.
Publicado: (2022)

Loss of Xenopus tropicalis EMSY causes impairment of gastrulation and upregulation of p53
por: Rana, Amer A., et al.
Publicado: (2011)

EMSY expression affects multiple components of the skin barrier with relevance to atopic dermatitis
por: Elias, Martina S., et al.
Publicado: (2019)

The EMSY Gene Collaborates with CCND1 in Non-Small Cell Lung Carcinogenesis
por: Baykara, Onur, et al.
Publicado: (2017)

Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients
por: Nurmi, Anna, et al.
Publicado: (2019)

BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment
por: Ampuja, Minna, et al.
Publicado: (2013)

Polymorphisms in the airway epithelium related genes CDHR3 and EMSY are associated with asthma susceptibility
por: Zhang, Miaomiao, et al.
Publicado: (2020)

Data missingness in the Michigan NEMSIS (MI-EMSIS) dataset: a mixed-methods study
por: Abir, Mahshid, et al.
Publicado: (2021)

High EMSY expression defines a BRCA‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum
por: Hollis, Robert L., et al.
Publicado: (2019)

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
por: Grill, Sabine, et al.
Publicado: (2020)

Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer
por: Rolfes, Muriel, et al.
Publicado: (2022)

PALB2 variants in hereditary and unselected Finnish Prostate cancer cases
por: Pakkanen, Sanna, et al.
Publicado: (2009)

RETRACTED ARTICLE: DGUOK-AS1 promotes the proliferation cervical cancer through regulating miR-653-5p/EMSY
por: Yan, Anqi, et al.
Publicado: (2020)

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility
por: Liu, Mengyuan, et al.
Publicado: (2020)

A novel germline BRCA1 mutation identified in a family with hereditary breast and ovarian cancer syndrome
por: Wu, Yanmei, et al.
Publicado: (2021)

Hereditary breast and ovarian cancer
por: Gronwald, Jacek, et al.
Publicado: (2008)

Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4–1 and NRDP1, in primary breast cancer
por: Luhtala, Satu, et al.
Publicado: (2018)

SGMS2 in primary osteoporosis with facial nerve palsy
por: Pihlström, Sandra, et al.
Publicado: (2023)

Spectrum of tumors in the families with Hereditary Breast Ovarian Cancer syndrome carrying germline mutations in BRCA1 and 2 genes
por: Budryk, M, et al.
Publicado: (2012)

Germline CDH1 deletions in hereditary diffuse gastric cancer families
por: Oliveira, Carla, et al.
Publicado: (2009)

Identification of Germline Variants in Patients with Hereditary Cancer Syndromes in Northeast Mexico
por: Pérez-Ibave, Diana Cristina, et al.
Publicado: (2023)

A multi-omics study to characterize the transdifferentiation of human dermal fibroblasts to osteoblast-like cells
por: Pihlström, Sandra, et al.
Publicado: (2022)

ARLTS1 and Prostate Cancer Risk - Analysis of Expression and Regulation
por: Siltanen, Sanna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l0rk8g5uddid3han37bf1lctth